GALMOZZI, ENRICO
 Distribuzione geografica
Continente #
EU - Europa 3.602
NA - Nord America 2.827
AS - Asia 2.573
Continente sconosciuto - Info sul continente non disponibili 390
SA - Sud America 260
AF - Africa 50
OC - Oceania 24
Totale 9.726
Nazione #
US - Stati Uniti d'America 2.666
GB - Regno Unito 1.394
CN - Cina 914
SG - Singapore 650
DE - Germania 601
IT - Italia 462
BD - Bangladesh 296
SE - Svezia 268
FR - Francia 238
RU - Federazione Russa 195
BR - Brasile 191
HK - Hong Kong 166
CA - Canada 104
IN - India 102
VN - Vietnam 98
NL - Olanda 89
TR - Turchia 86
IE - Irlanda 69
FI - Finlandia 60
DK - Danimarca 58
UA - Ucraina 58
KR - Corea 57
JP - Giappone 53
TW - Taiwan 39
EU - Europa 36
MX - Messico 36
ID - Indonesia 30
PL - Polonia 27
CO - Colombia 24
AU - Australia 23
EG - Egitto 16
AR - Argentina 15
GR - Grecia 15
ES - Italia 14
BE - Belgio 12
IQ - Iraq 10
VE - Venezuela 10
MA - Marocco 9
RO - Romania 9
TH - Thailandia 9
IR - Iran 8
PK - Pakistan 8
EC - Ecuador 7
UZ - Uzbekistan 7
CR - Costa Rica 6
PH - Filippine 6
TN - Tunisia 6
AT - Austria 5
JM - Giamaica 5
MM - Myanmar 5
PE - Perù 5
CH - Svizzera 4
CI - Costa d'Avorio 4
DZ - Algeria 4
IL - Israele 4
PT - Portogallo 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
HU - Ungheria 3
LB - Libano 3
MY - Malesia 3
NP - Nepal 3
RS - Serbia 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
HN - Honduras 2
KE - Kenya 2
KH - Cambogia 2
LU - Lussemburgo 2
PR - Porto Rico 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GN - Guinea 1
GT - Guatemala 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
SN - Senegal 1
TM - Turkmenistan 1
ZW - Zimbabwe 1
Totale 9.372
Città #
Southend 1.310
Singapore 387
Ashburn 244
Chandler 240
Beijing 186
San Jose 158
Hong Kong 147
Milan 145
Seattle 125
Wilmington 95
Hanover 92
Council Bluffs 90
Princeton 89
Los Angeles 87
Santa Clara 76
Dallas 74
Frankfurt am Main 74
New York 70
Dublin 66
Cambridge 58
Ann Arbor 54
Woodbridge 52
Fairfield 49
Toronto 46
Houston 45
Mountain View 43
Dearborn 42
Shanghai 41
Boardman 39
Nanjing 39
Buffalo 36
Lauterbourg 36
Munich 34
Guangzhou 32
Andover 31
Redmond 30
Ho Chi Minh City 29
Moscow 29
Redwood City 29
Des Moines 28
Scranton 28
Bengaluru 27
Rome 26
Somerville 26
Jacksonville 25
São Paulo 23
Sakarya 22
Kiez 21
Hanoi 20
Bogotá 19
Hangzhou 19
Helsinki 19
North Bergen 19
Phoenix 19
Taichung 18
Warsaw 18
Columbus 17
Serra 17
Berlin 15
Cangzhou 15
Changsha 15
Jakarta 15
Piscataway 15
Tokyo 15
Hebei 14
Odernheim 14
The Dalles 14
Tianjin 14
Jinan 13
Nürnberg 13
Shenzhen 13
Grafing 12
Montreal 12
Saint Petersburg 12
Shenyang 12
Athens 11
Eitensheim 11
Hamburg 11
Hefei 11
Naples 11
Ottawa 11
Turin 11
Brussels 10
Fuzhou 10
Orem 10
Bari 9
Brooklyn 9
Groningen 9
Guadalajara 9
Mumbai 9
Nuremberg 9
Chengdu 8
Chicago 8
Jiaxing 8
Margão 8
Nanchang 8
Newark 8
Taipei 8
Turku 8
Brisbane 7
Totale 5.425
Nome #
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumorigenic potential 835
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs 754
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients 423
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent 362
Donor/recipient match of IL28B to predict interferon response in recurrent hepatitis C 305
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 303
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 300
Cancer stem cells and therapeutic perspectives 274
Homozygosity for the PNPLA3/Adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 273
Limited utility of ITPA deficiency to predict early anemia in HCV patients with advanced fibrosis receiving telaprevir 267
Increased levels of the CD40 : CD40 ligand dyad in the cerebrospinal fluid of rats with vitamin B12(cobalamin)-deficient central neuropathy 249
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C 242
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease 236
Allelic inhibition of displacement activity : a simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms 236
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients 233
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 233
Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy 233
TLL1 Variants do not predict hepatocellular carcinoma development in hcv cirrhotic patients treated with direct-acting antivirals 232
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance 224
A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype 221
NPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 215
Homozygosity for the PNPLA3/Adiponutrin I148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 207
Identification of stem cell like population in human melanoma 206
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease 206
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B 200
PNPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 195
Interaction between the PNPLA3 I148M mutation, body weight, and steatosis, in determining the progression to cirrhosis in hereditary hemochromatosis 194
PNPLA3/adiponutrin genotype is strongly associated with metabolic syndrome components and liver damage in patients with non-alcoholic fatty liver disease 191
Systematic review with meta-analysis : do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection? 174
CD133 postive cellular population in human melanoma 173
I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease 168
Homozygosity for the patatin-like phospholipase-3/adiponutrin i148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 167
CD133 positive cellular population in human melanoma 163
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease 161
Genetic testing for hepatocellular carcinoma : an ambitious goal still to achieve 150
PNPLA3/adiponutrin genotype is strongly associated with metabolic syndrome components and liver damage in patients with nonalcoholic liver disease 144
Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotype 130
Letter: Do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection? Authors' reply 126
Letter: Does the IFNL4 gene discovery really provide a causal role for the IL28B haplotype blocks? 121
Totale 9.726
Categoria #
all - tutte 23.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022685 0 0 32 77 90 80 73 38 67 67 51 110
2022/2023728 102 101 80 71 68 132 14 43 63 9 32 13
2023/2024465 25 32 23 36 92 40 34 24 21 35 44 59
2024/20251.164 32 141 42 164 101 51 44 95 48 104 106 236
2025/20262.432 287 166 170 168 243 173 198 145 193 117 342 230
2026/2027436 268 160 8 0 0 0 0 0 0 0 0 0
Totale 9.726